Status:
COMPLETED
Continuous Rhythm Monitoring With Implantable Cardiac Monitors And Wearable Devices With Real-time Smartphone Alerts During AF Episodes
Lead Sponsor:
Oxford University Hospitals NHS Trust
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Atrial fibrillation (AF) is the most common arrhythmia affecting 1.3 million people in the UK. AF causes an irregular and fast heartbeat, which makes the heart pump poorly. As a result, blood clots ma...
Eligibility Criteria
Inclusion
- Participant is willing and able to give informed consent for participation in the trial.
- Male or Female aged 18 years or above.
- Paroxysmal AF with symptoms, Holter recording and/or implantable device evidence of \>1 but \<15 episodes of AF in the last 3 months.
- Persistent AF scheduled for repeat cardioversion (i.e. having had at least one prior cardioversion).
- Currently have an Apple IOS or Android smartphone.
Exclusion
- Diagnosis of permanent AF.
- Contra-indications for implantable cardiac monitor.
- Visual or physical impairment that prevents ability to read and acknowledge smartphone/watch notifications.
- Unable to comply with the follow-up schedule.
- Do not have Apple IOS or android smartphone.
Key Trial Info
Start Date :
November 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05207150
Start Date
November 26 2021
End Date
June 15 2023
Last Update
August 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oxford Univeristy Hospitals NHS Foundation Trust
Oxford, Oxfordshire, United Kingdom, OX89DU